跳至主要内容
临床试验/ISRCTN33957677
ISRCTN33957677已完成不适用

A pilot study to examine the safety and efficacy of posterior juxta-scleral (80 mg) triamcinolone acetonide, administration, in addition to Visudyne (verteporfin) photodynamic therapy for predominantly classic choroidal neovascularisation secondary to age-related macular degeneration: an open-label, randomised, active controlled trial

King's College Hospital (UK)0 个研究点目标入组 80 人开始时间: 2008年1月18日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age 50 years or older, male and female
  • 2. Clinical diagnosis of age-related macular degeneration (AMD)
  • 3. Subfoveal choroidal neovascularisation (CNV) confirmed by fluorescein angiography
  • 4. Best corrected visual acuity of 35 letters on Early Treatment Diabetic Retinopathy Study (ETDRS) chart

排除标准

  • 1. Inability to understand or sign consent form
  • 2. The patient has a current medical condition or history of a medical condition that would be likely to preclude scheduled study visits
  • 3. Patient has a current ophthalmic condition or history of an ophthalmic condition that might compromise the assessment of the treatment
  • 4. Signs of a myopic retina or refraction of greater than -8 dioptres in their current or previous glasses prescription
  • 5. Signs of other retinal conditions that may have caused the CNV such as angioid streaks, choroidal rupture, and old chorio-retinitis
  • 6. Open angle glaucoma
  • 7. At increased risk of developing glaucoma such as having; pigment dispersion syndrome or pseudoexfoliation
  • 8. Unable to have a good quality fluorescein angiogram taken, e.g., due to head tremor or media opacity

研究者

发起方
King's College Hospital (UK)

相似试验

A pilot study to examine the safety and efficacy of... | 临床试验